Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 316 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 03/17/23
End: 01/01/24
Due: 01/01/25
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 01/01/28
Due: 01/01/29
Phase: N/A
Priority: Normal
Start: 03/22/23
End: 09/22/24
Due: 09/22/25
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 04/04/22
End: 02/01/25
Due: 02/01/26
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 03/01/19
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 01/25/19
End: 05/15/25
Due: 05/15/26
Phase: N/A
Priority: Normal
Start: 03/11/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/03/22
End: 04/03/23
Due: 04/03/24
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 03/27/25
Due: 03/27/26
Phase: N/A
Priority: Normal
Start: 02/11/20
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 11/13/23
End: 11/10/25
Due: 11/10/26
Phase: N/A
Priority: Normal
Start: 02/25/21
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 01/19/22
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 06/25/19
End: 06/01/22
Due: 06/01/23
Phase: N/A
Priority: Normal
Start: 12/29/24
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 05/01/29
Due: 05/01/30
Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
Phase: N/A
Priority: Normal
Start: 02/20/17
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 05/31/21
Due: 05/31/22